Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1204   
Active ingredient: Sirolimus
Indication: Prevention of arteriovenous access dysfunction in patients undergoing surgical creation of an arteriovenous access for haemodialysis
Sponsor: S-cubed Ltd
Boston House, Grove Business Park, Wantage, Oxfordshire OX12 9FF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/117/13 (2013)8051 of 13/11/2013
1/09/2017 Change of name and/or address of sponsor